Klepsch, V., Hermann-Kleiter, N., Do-Dinh, P., Jakic, B., Offermann, A., Efremova, M., . . . Baier, G. (2018). Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. Nat Commun.
Chicago Style CitationKlepsch, Victoria, et al. "Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade." Nat Commun 2018.
MLA CitationKlepsch, Victoria, et al. "Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade." Nat Commun 2018.
Warning: These citations may not always be 100% accurate.